Works matching DE "CYTOCHROME P-450 CYP3A"
Results: 685
Physiologically based pharmacokinetic modelling to predict potential drug–drug interactions of dersimelagon (MT‐7117).
- Published in:
- British Journal of Clinical Pharmacology, 2025, v. 91, n. 2, p. 451, doi. 10.1111/bcp.16271
- By:
- Publication type:
- Article
Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 1, p. 57, doi. 10.1080/17512433.2023.2295428
- By:
- Publication type:
- Article
Effects of baicalein and fangchinoline on abemaciclib metabolism in vivo and in vitro and molecular docking analysis.
- Published in:
- Arabian Journal of Chemistry, 2025, v. 18, n. 1, p. N.PAG, doi. 10.1016/j.arabjc.2024.106073
- By:
- Publication type:
- Article
The Promise of Pharmacogenomics in Pediatric Transplantation: A Step Toward Precision Medicine.
- Published in:
- Pediatric Transplantation, 2025, v. 29, n. 2, p. 1, doi. 10.1111/petr.70045
- By:
- Publication type:
- Article
Progress in Clinical Pharmacology in China: An Ongoing Evolution.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 609, doi. 10.1002/cpt.3549
- By:
- Publication type:
- Article
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 732, doi. 10.1002/cpt.3506
- By:
- Publication type:
- Article
A Phase I Trial of the Pharmacokinetic Interaction Between Cannabidiol and Tacrolimus.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 3, p. 716, doi. 10.1002/cpt.3504
- By:
- Publication type:
- Article
The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID‐19 Patients: A Physiologically Based Pharmacokinetic Modeling Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 554, doi. 10.1002/cpt.3491
- By:
- Publication type:
- Article
Building Confidence in Physiologically Based Pharmacokinetic Modeling of CYP3A Induction Mediated by Rifampin: An Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 403, doi. 10.1002/cpt.3477
- By:
- Publication type:
- Article
PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first‐pass metabolism?
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 130, doi. 10.1002/psp4.13249
- By:
- Publication type:
- Article
Population pharmacokinetic and pharmacodynamic model of evogliptin: Severe uremia increases the bioavailability of evogliptin.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 2, p. 246, doi. 10.1002/psp4.13263
- By:
- Publication type:
- Article
Effect of isavuconazole on the concentration of tacrolimus in a patient with genotype CYP3A5*1/*3: a case report.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40780-025-00427-4
- By:
- Publication type:
- Article
A potentially lethal interaction: Migraine, human immunodeficiency virus and ergotism - A primary care case report.
- Published in:
- Malaysian Family Physician, 2025, p. 1, doi. 10.51866/cr.748
- By:
- Publication type:
- Article
A Drug–Drug Interaction Study of Mobocertinib and Midazolam, a Cytochrome P450 3A Substrate, in Patients With Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Pharmacology in Drug Development, 2025, v. 14, n. 3, p. 252, doi. 10.1002/cpdd.1500
- By:
- Publication type:
- Article
High-performance PBPK model for predicting CYP3A4 induction-mediated drug interactions: a refined and validated approach.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1521068
- By:
- Publication type:
- Article
Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study.
- Published in:
- Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1525991
- By:
- Publication type:
- Article
Effects of CYP3A5 polymorphism and renal impairment on the drug interaction between venetoclax and fluconazole in acute myeloid leukaemia patients.
- Published in:
- Xenobiotica, 2025, v. 55, n. 1, p. 37, doi. 10.1080/00498254.2024.2442431
- By:
- Publication type:
- Article
Discovery of a Novel Multitarget Analgesic Through an In Vivo-Guided Approach.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 205, doi. 10.3390/ph18020205
- By:
- Publication type:
- Article
CYP3A Mediates an Unusual C(sp<sup>2</sup>)−C(sp<sup>3</sup>) Bond Cleavage via Ipso‐Addition of Oxygen in Drug Metabolism.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 23, p. 1, doi. 10.1002/ange.202405197
- By:
- Publication type:
- Article
Rational Design of a Two‐Photon Fluorescent Probe for Human Cytochrome P450 3A and the Visualization of Mechanism‐Based Inactivation.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 5, p. 1, doi. 10.1002/ange.202113191
- By:
- Publication type:
- Article
Does One Size Fits All?
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1099, doi. 10.1007/s10557-024-07625-6
- By:
- Publication type:
- Article
Mutant CYP3A4/5 Correlated with Clinical Outcomes by Affecting Rivaroxaban Pharmacokinetics and Pharmacodynamics in Patients with Atrial Fibrillation.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 6, p. 1315, doi. 10.1007/s10557-023-07495-4
- By:
- Publication type:
- Article
Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 747, doi. 10.1007/s10557-023-07443-2
- By:
- Publication type:
- Article
Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 459, doi. 10.1007/s10557-022-07405-0
- By:
- Publication type:
- Article
Quantitative analysis of the impact of membrane permeability on intestinal first‐pass metabolism of CYP3A substrates.
- Published in:
- Biopharmaceutics & Drug Disposition, 2024, v. 45, n. 1, p. 3, doi. 10.1002/bdd.2379
- By:
- Publication type:
- Article
Evaluation of bleeding and anticoagulation markers by edoxaban and low‐dose cyclosporine: A case series study.
- Published in:
- Biopharmaceutics & Drug Disposition, 2022, v. 43, n. 5, p. 192, doi. 10.1002/bdd.2332
- By:
- Publication type:
- Article
Effects of osthol on activity, mRNA and protein expression of Cyp3a in rats in vivo.
- Published in:
- Biopharmaceutics & Drug Disposition, 2020, v. 41, n. 1/2, p. 64, doi. 10.1002/bdd.2214
- By:
- Publication type:
- Article
Effects of Aspirin on the Bioavailability and Pharmacokinetics of Repaglinide: Possible Role of Cytochrome P450 3A Isoforms Inhibition by Aspirin.
- Published in:
- Pharmaceutical Chemistry Journal, 2022, v. 55, n. 11, p. 1151, doi. 10.1007/s11094-022-02551-z
- By:
- Publication type:
- Article
Insights into oral bioavailability enhancement of therapeutic herbal constituents by cytochrome P450 3A inhibition.
- Published in:
- Drug Metabolism Reviews, 2021, v. 53, n. 4, p. 491, doi. 10.1080/03602532.2021.1917598
- By:
- Publication type:
- Article
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18360
- By:
- Publication type:
- Article
The effect of gene polymorphism on ticagrelor metabolism: an in vitro study of 22 CYP3A4 variants in Chinese Han population.
- Published in:
- PeerJ, 2024, p. 1, doi. 10.7717/peerj.18109
- By:
- Publication type:
- Article
Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.
- Published in:
- PeerJ, 2023, p. 1, doi. 10.7717/peerj.15844
- By:
- Publication type:
- Article
TNP and its analogs: Modulation of IP6K and CYP3A4 inhibition.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 269, doi. 10.1080/14756366.2021.2000404
- By:
- Publication type:
- Article
Evaluation of weight loss supplements toxicity in rifampicin pretreated HepG2 cells.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 257, doi. 10.33320/maced.pharm.bull.2023.69.03.126
- By:
- Publication type:
- Article
In silico prediction of physicochemical, pharmacokinetic and toxicological properties of sulforaphane.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 331, doi. 10.33320/maced.pharm.bull.2022.68.03.159
- By:
- Publication type:
- Article
Toxicity assessment of weight loss supplements and possible interaction risk with lipid-lowering and antihypertensive drugs in HepG2 cell line.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 321, doi. 10.33320/maced.pharm.bull.2022.68.03.154
- By:
- Publication type:
- Article
Tacrolimus Concentration Is Effectively Predicted Using Combined Clinical and Genetic Factors in the Perioperative Period of Kidney Transplantation and Associated with Acute Rejection.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The effects of vitamins C and E on the redox parameters of cytochrome P450 3A4.
- Published in:
- Zeitschrift für Physikalische Chemie, 2023, v. 237, n. 12, p. 1925, doi. 10.1515/zpch-2023-0303
- By:
- Publication type:
- Article
Tolterodine is a novel candidate for assessing CYP3A4 activity through metabolic volatiles to predict drug responses.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-86450-9
- By:
- Publication type:
- Article
Author Correction: Responses in organs, sperm, steroid hormones and CYP450 enzyme in male mice treated by quinestrol only or in conjunction with clarithromycin.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
OCT1 (SLC22A1) transporter kinetics and regulation in primary human hepatocyte 3D spheroids.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-67192-6
- By:
- Publication type:
- Article
Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61544-y
- By:
- Publication type:
- Article
CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-58104-9
- By:
- Publication type:
- Article
CYP3A-Mediated Carbon–Carbon Bond Cleavages in Drug Metabolism.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 9, p. 1125, doi. 10.3390/biom14091125
- By:
- Publication type:
- Article
The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 717, doi. 10.3390/biom14060717
- By:
- Publication type:
- Article
Exploring the Potential of Sulfur Moieties in Compounds Inhibiting Steroidogenesis.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1349, doi. 10.3390/biom13091349
- By:
- Publication type:
- Article
Differential Metabolic Stability of 4α,25- and 4β,25-Dihydroxyvitamin D 3 and Identification of Their Metabolites.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 7, p. 1036, doi. 10.3390/biom13071036
- By:
- Publication type:
- Article
Functional and Structural Impact of Deleterious Missense Single Nucleotide Polymorphisms in the NR3C1, CYP3A5, and TNF-α Genes: An In Silico Analysis.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1307, doi. 10.3390/biom12091307
- By:
- Publication type:
- Article
Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 853, doi. 10.3390/biom12060853
- By:
- Publication type:
- Article
Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 2, p. 165, doi. 10.3390/biom12020165
- By:
- Publication type:
- Article